Retail Clinics Market Trends

Growth Drivers

Increase in Strep Throat Cases - Strep throat is a bacterial infection that leads to throat swelling and pain. The bacteria in group A Streptococcus end up causing this common condition. Children and adults of all ages get strep throat. However, it is especially common among children aged 5 to 15. Therefore, increasing cases of strep throat is one of the leading factors for the growth of retail clinics market. For instance, every year, approximately 610 million people globally contract strep throat, with many of them are children.
Global Upsurge in Urinary Tract Infection - Globally, there are anticipated to be 152 million UTI infection cases annually, costing more than USD 6.5 billion in direct medical expenses.
Staggering Increase in COVID-19 Detection Tests - Austria had conducted the most COVID-19 tests per 1 million population among the countries which are most seriously affected by the pandemic as of September 12, 2022. Whereas, the United States has administered nearly over 1 billion COVID-19 tests in total.
Rise in Urbanization – As per the World Bank, currently, more than 50% of the world's population resides in cities. The number of people living in urban areas is estimated to rise more than double to 6 billion by 2045.
Escalation of Retail Clinics for Immunization – According to the Centers for Disease Control and Prevention, more than 266.5 million doses of the COVID-19 vaccine had been given and recorded by Federal Retail Pharmacy Program participants in the US as of September 15, 2022. This comprises are the 8 million doses given on-site to long-term care facilities. With more than 41,000 sites nationwide, the program has a total of 21 retail pharmacy partners.

Challenges

Insufficient Infrastructure for Retail Clinics – In the developing nations, owing to the slow rate of development and less GDP growth, insufficient amount of expense is spent on infrastructure for retail clinics. This trend is expected to pose as a challenge to market growth.
Inadequacy of Provision for Treating Complex Diseases
Stringent Governmental Regulations

Retail Clinics Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	13.7%
Base Year Market Size (2024)	USD 5.17 billion
Forecast Year Market Size (2037)	USD 27.79 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of retail clinics is estimated at USD 5.74 billion.

The retail clinics market size was valued at USD 5.17 billion in 2024 and is projected to cross USD 27.79 billion by the end of 2037, expanding at more than 13.7% CAGR during the forecast period i.e., between 2025-2037. Increase in strep throat cases, global upsurge in urinary tract infection, staggering increase in covid-19 detection tests, and rise in urbanization will drive the market growth.

North America industry is poised to dominate majority revenue share by 2037, backed by existence of key retail clinic providers along with growing geriatric population, increasing prevalence of sinusitis infections, and sufficient insurance coverage provided by these retail clinics in the region.

The major players in the market include The Kroger Co, .CVS Health Corporation, Walmart Inc., Walgreen Co., Bellin Health, Concentra, Inc., MedExpress, Advocate Health Care, Kaiser Foundation Health Plan, Inc., Nextcare Claims Management LLC.

Retail Clinics Market Trends